Your browser doesn't support javascript.
loading
Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer.
Quinn, Michael C J; McCue, Karen; Shi, Wei; Johnatty, Sharon E; Beesley, Jonathan; Civitarese, Andrew; O'Mara, Tracy A; Glubb, Dylan M; Tyrer, Jonathan P; Armasu, Sebastian M; Ong, Jue-Sheng; Gharahkhani, Puya; Lu, Yi; Gao, Bo; Patch, Ann-Marie; Fasching, Peter A; Beckmann, Matthias W; Lambrechts, Diether; Vergote, Ignace; Velez Edwards, Digna R; Beeghly-Fadiel, Alicia; Benitez, Javier; Garcia, Maria J; Goodman, Marc T; Dörk, Thilo; Dürst, Matthias; Modugno, Francesmary; Moysich, Kirsten; du Bois, Andreas; Pfisterer, Jacobus; Bauman, Klaus; Karlan, Beth Y; Lester, Jenny; Cunningham, Julie M; Larson, Melissa C; McCauley, Bryan M; Kjaer, Susanne K; Jensen, Allan; Hogdall, Claus K; Hogdall, Estrid; Schildkraut, Joellen M; Riggan, Marjorie J; Berchuck, Andrew; Cramer, Daniel W; Terry, Kathryn L; Bjorge, Line; Webb, Penelope M; Friedlander, Michael; Pejovic, Tanja; Moffitt, Melissa.
Afiliação
  • Quinn MCJ; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • McCue K; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Shi W; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Johnatty SE; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Beesley J; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Civitarese A; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • O'Mara TA; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Glubb DM; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Tyrer JP; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
  • Armasu SM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Ong JS; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Gharahkhani P; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Lu Y; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Gao B; Crown Princess Mary Cancer Care Centre, Westmead Hospital, Sydney, New South Wales, Australia.
  • Patch AM; Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
  • Fasching PA; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Beckmann MW; Division of Hematology and Oncology, Department of Medicine, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, California.
  • Lambrechts D; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Vergote I; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Velez Edwards DR; VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  • Beeghly-Fadiel A; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
  • Benitez J; Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Garcia MJ; Department of Obstetrics and Gynecology, Vanderbilt Epidemiology Center, Vanderbilt Genetics Institute, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Goodman MT; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Dörk T; Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
  • Dürst M; Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
  • Modugno F; Computational Oncology Group, Spanish National Cancer Centre (CNIO), Madrid, Spain.
  • Moysich K; Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • du Bois A; Department of Biomedical Sciences, Community and Population Health Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Pfisterer J; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Bauman K; Department of Gynecology, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.
  • Karlan BY; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Lester J; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.
  • Cunningham JM; Womens Cancer Research Center, Magee-Womens Research Institute and Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Larson MC; Division of Cancer Prevention and Population Sciences, Cancer Pathology & Prevention, Roswell Park Cancer Institute, Buffalo, New York.
  • McCauley BM; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
  • Kjaer SK; Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
  • Jensen A; Gynecologic Oncology Center, Kiel, Germany.
  • Hogdall E; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
  • Schildkraut JM; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
  • Riggan MJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Berchuck A; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Cramer DW; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Terry KL; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Bjorge L; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Webb PM; Department of Lifestyle, Reproduction and Cancer, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Friedlander M; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Pejovic T; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Moffitt M; Department of Lifestyle, Reproduction and Cancer, Danish Cancer Society Research Center, Copenhagen, Denmark.
Cancer Epidemiol Biomarkers Prev ; 30(9): 1669-1680, 2021 09.
Article em En | MEDLINE | ID: mdl-34162658
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Peptídeos e Proteínas de Sinalização Intracelular / Proteína Homóloga à Proteína-1 Relacionada à Autofagia / Carcinoma Epitelial do Ovário Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Peptídeos e Proteínas de Sinalização Intracelular / Proteína Homóloga à Proteína-1 Relacionada à Autofagia / Carcinoma Epitelial do Ovário Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália